Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology

Alexander Kamyshnyi1, Inna Krynytska2, Victoriya Matskevych3

  • 1Department of Microbiology, Virology and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.

Insights

Arterial hypertension (AH) is a common comorbidity in COVID-19 patients, potentially worsening outcomes. Further research is needed on mechanisms like ACE2 and immune response, and the role of AH-linked ACE2 gene polymorphisms.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Genetics

Background:

  • COVID-19, caused by SARS-CoV-2, presents significant global health challenges.
  • Arterial hypertension (AH) is a prevalent comorbidity in COVID-19 patients, associated with poorer outcomes and increased ICU admission.
  • The precise mechanisms linking AH to adverse COVID-19 prognosis remain unclear.

Purpose of the Study:

  • To explore the potential mechanisms connecting arterial hypertension and COVID-19 severity.
  • To highlight the importance of blood pressure control and monitoring in hypertensive COVID-19 patients.
  • To investigate the role of ACE2 and immune dysregulation in the context of AH and SARS-CoV-2 infection.

Main Methods:

  • Review of current clinical data and existing literature on COVID-19 and arterial hypertension.
  • Analysis of the proposed roles of angiotensin-converting enzyme 2 (ACE2) in both AH pathophysiology and SARS-CoV-2 infection.
  • Examination of immune system dysregulation, including cytokine storms and T helper cell imbalance, in relation to AH and COVID-19.

Main Results:

  • Arterial hypertension is a frequent comorbidity in COVID-19, linked to worse clinical outcomes.
  • Potential mechanisms include the involvement of the ACE2 pathway and immune system dysregulation (cytokine storm).
  • The specific impact of AH-linked ACE2 gene polymorphisms on SARS-CoV-2 infection risk and severity requires further investigation.

Conclusions:

  • Optimizing blood pressure control is crucial for hypertensive patients during COVID-19 infection.
  • Close monitoring for cardiovascular and other complications is essential for this patient group.
  • Further research into the genetic and immunological links between AH and COVID-19 is warranted to improve patient management and outcomes.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
333
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
669
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
150
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
2.1K